Correlation Between RepliCel Life and Premium Income

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RepliCel Life and Premium Income at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RepliCel Life and Premium Income into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RepliCel Life Sciences and Premium Income, you can compare the effects of market volatilities on RepliCel Life and Premium Income and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RepliCel Life with a short position of Premium Income. Check out your portfolio center. Please also check ongoing floating volatility patterns of RepliCel Life and Premium Income.

Diversification Opportunities for RepliCel Life and Premium Income

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between RepliCel and Premium is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding RepliCel Life Sciences and Premium Income in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Premium Income and RepliCel Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RepliCel Life Sciences are associated (or correlated) with Premium Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Premium Income has no effect on the direction of RepliCel Life i.e., RepliCel Life and Premium Income go up and down completely randomly.

Pair Corralation between RepliCel Life and Premium Income

Given the investment horizon of 90 days RepliCel Life Sciences is expected to under-perform the Premium Income. In addition to that, RepliCel Life is 6.07 times more volatile than Premium Income. It trades about -0.02 of its total potential returns per unit of risk. Premium Income is currently generating about -0.01 per unit of volatility. If you would invest  716.00  in Premium Income on September 12, 2024 and sell it today you would lose (80.00) from holding Premium Income or give up 11.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

RepliCel Life Sciences  vs.  Premium Income

 Performance 
       Timeline  
RepliCel Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RepliCel Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Premium Income 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Premium Income are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Premium Income may actually be approaching a critical reversion point that can send shares even higher in January 2025.

RepliCel Life and Premium Income Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RepliCel Life and Premium Income

The main advantage of trading using opposite RepliCel Life and Premium Income positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RepliCel Life position performs unexpectedly, Premium Income can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Premium Income will offset losses from the drop in Premium Income's long position.
The idea behind RepliCel Life Sciences and Premium Income pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope